Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Amyloidosis: Diagnosis, Treatment, Outcomes

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the molecular mechanisms, diagnosis, treatment, and prognosis of amyloidosis, with a particular emphasis on transthyretin-related cardiac and familial amyloid polyneuropathy. It covers topics such as RNAi therapy, cardiovascular magnetic resonance, and immunoglobulin light chain involvement.

173
Works

How has Amyloidosis: Diagnosis, Treatment, Outcomes's publication output changed over time?

ScholarIQpublication output · 2005–2024

Output grew0% over the shown period — from 1 works in 2005 to 1 in 2024.

1
1
1
1
1
3
3
2
1
1
2005200720112015201620182019202020232024

What are the most-cited papers on Amyloidosis: Diagnosis, Treatment, Outcomes?

ScholarIQmost cited works
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David Adams, Alejandra González‐Duarte, William O’Riordan, Chih‐Chao Yang, Mitsuharu Ueda, Arnt V. Kristen, Ivailo Tournev, Hartmut Schmidt, Teresa Coelho, John L. Berk, Kon-Ping Lin, Giuseppe Vita, Shahram Attarian, Violaine Planté‐Bordeneuve, Michelle M. Mezei, Josep M. Campistol, Juan Buades, Thomas H. Brannagan, Byoung J. Kim, Jeeyoung Oh, Yeşim Parman, Yoshiki Sekijima, Philip N. Hawkins, Scott D. Solomon, Michael Polydefkis, P. James B. Dyck, Pritesh J. Gandhi, Sunita Goyal, Jihong Chen, Andrew Strahs, Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, Jared Gollob, Ole B. Suhr
New England Journal of Medicine. 20182,975 CitationsOPEN ACCESS
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Matthew J. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott, Giampaolo Merlini, Márcia Waddington‐Cruz, Arnt V. Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy, Brian Drachman, Sanjiv J. Shah, Mazen Hanna, Daniel P. Judge, Alexandra I. Barsdorf, Peter M. Huber, Terrell A. Patterson, Steve Riley, Jennifer Schumacher, Michelle Stewart, Marla B. Sultan, Claudio Rapezzi
New England Journal of Medicine. 20182,771 CitationsOPEN ACCESS
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz, Ray Comenzo, Rodney H. Falk, Jean Paul Fermand, Bouke P. C. Hazenberg, Philip N. Hawkins, Giampaolo Merlini, Philippe Moreau, Pierre Ronco, Vaishali Sanchorawala, Orhan Sezer, Alan Solomon, G Grateau
American Journal of Hematology. 20051,426 Citations
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Mathew S. Maurer, Sabahat Bokhari, Thibaud Damy, Sharmila Dorbala, Brian Drachman, Marianna Fontana, Martha Grogan, Arnt V. Kristen, Isabelle Lousada, José Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Ronald Witteles, Giampaolo Merlini
Circulation Heart Failure. 2019559 CitationsOPEN ACCESS
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
Nelson Leung, Frank Bridoux, Vecihi Batuman, Aristeidis Chaidos, Paul Cockwell, Vivette D. D’Agati, Angela Dispenzieri, Fernando C. Fervenza, Jean-Paul Fermand, Simon Gibbs, Julian D. Gillmore, Guillermo A. Herrera, Arnaud Jaccard, Dragan Jevremović, Efstathios Kastritis, Vishal Kukreti, Robert A. Kyle, Helen J. Lachmann, Christopher P. Larsen, Heinz Ludwig, Glen S. Markowitz, Giampaolo Merlini, Peter Mollee, Maria M. Picken, S. Vincent Rajkumar, Virginie Royal, Paul W. Sanders, Sanjeev Sethi, Christopher P. Venner, Peter M. Voorhees, Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr
Nature Reviews Nephrology. 2018543 CitationsOPEN ACCESS

Where is Amyloidosis: Diagnosis, Treatment, Outcomes research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Amyloidosis: Diagnosis, Treatment, Outcomes is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
7%
Green
13%
Hybrid
27%
Bronze
33%
Closed
20%

Related on ScholarIQ

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Paper
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Paper
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Paper
M-Type Phospholipase A <sub>2</sub> Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Paper
International Consensus Diagnostic Criteria for Autoimmune Pancreatitis
Paper
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid
Paper
470M+ articles · free account